Psoriasis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rapp, 1999, Psoriasis causes as much disability as other major medical diseases, J Am Acad Dermatol, 41, 401, 10.1016/S0190-9622(99)70112-X
Dubertret, 2006, European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey, Br J Dermatol, 155, 729, 10.1111/j.1365-2133.2006.07405.x
Christophers, 2001, Psoriasis—epidemiology and clinical spectrum, Clin Exp Dermatol, 26, 314, 10.1046/j.1365-2230.2001.00832.x
Augustin, 2010, Epidemiology and comorbidity of psoriasis in children, Br J Dermatol, 162, 633, 10.1111/j.1365-2133.2009.09593.x
Jacobson, 2011, Latitude and psoriasis prevalence, J Am Acad Dermatol, 65, 870, 10.1016/j.jaad.2009.05.047
Balato, 2013, Effect of weather and environmental factors on the clinical course of psoriasis, Occup Environ Med, 70, 600, 10.1136/oemed-2013-101505
Griffiths, 2007, Pathogenesis and clinical features of psoriasis, Lancet, 370, 263, 10.1016/S0140-6736(07)61128-3
Hägg, 2013, The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men, PLoS One, 8, e63619, 10.1371/journal.pone.0063619
Ortonne, 2009, Scalp psoriasis: European consensus on grading and treatment algorithm, J Eur Acad Dermatol Venereol, 23, 1435, 10.1111/j.1468-3083.2009.03372.x
Runne, 1993, Alopecia psoriatica. Charakteristika eines bisher negierten Krankheitsbildes, Hautarzt, 44, 691
Reich, 2009, Approach to managing patients with nail psoriasis, J Eur Acad Dermatol Venereol, 23, 15, 10.1111/j.1468-3083.2009.03364.x
Sugiura, 2014, The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants, J Dermatol Sci, 74, 187, 10.1016/j.jdermsci.2014.02.006
Marrakchi, 2011, Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis, N Engl J Med, 365, 620, 10.1056/NEJMoa1013068
Joyau, 2012, Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?, Clin Exp Rheumatol, 30, 700
Shmidt, 2012, Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010, J Am Acad Dermatol, 67, e179, 10.1016/j.jaad.2011.05.038
Besgen, 2010, Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: potential targets of a streptococcal-induced autoimmune response in psoriasis, J Immunol, 184, 5392, 10.4049/jimmunol.0903520
Martin, 1996, How great is the risk of further psoriasis following a single episode of acute guttate psoriasis?, Arch Dermatol, 132, 717, 10.1001/archderm.1996.03890300147032
Fotiadou, 2014, Management of psoriasis in adolescence, Adolesc Health Med Ther, 5, 25, 10.2147/AHMT.S36672
Ståhle, 2010, Juvenile psoriasis and its clinical management: a European expert group consensus, J Dtsch Dermatol Ges, 8, 812
Basavaraj, 2010, The role of drugs in the induction and/or exacerbation of psoriasis, Int J Dermatol, 49, 1351, 10.1111/j.1365-4632.2010.04570.x
Mahler, 2014, Psoriasis predisposition and occupational triggering factors in the appraisal of occupational medical expertises, J Dtsch Dermatol Ges, 12, 519, 10.1111/ddg.12262
Fry, 2007, Triggering psoriasis: the role of infections and medications, Clin Dermatol, 25, 606, 10.1016/j.clindermatol.2007.08.015
Schmitt, 2005, The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis, Dermatology, 210, 194, 10.1159/000083509
Langley, 2004, Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment, J Am Acad Dermatol, 51, 563, 10.1016/j.jaad.2004.04.012
Henes, 2014, High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study, Rheumatol Int, 34, 227, 10.1007/s00296-013-2876-z
Coates, 2013, Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study), Br J Dermatol, 168, 802, 10.1111/bjd.12190
Boehncke, 2010, Managing comorbid disease in patients with psoriasis, BMJ, 340, b5666, 10.1136/bmj.b5666
Nickoloff, 2007, Immunopathogenesis of psoriasis, Clin Rev Allergy Immunol, 33, 45, 10.1007/s12016-007-0039-2
Sabat, 2007, Immunopathogenesis of psoriasis, Exp Dermatol, 16, 779, 10.1111/j.1600-0625.2007.00629.x
Elder, 2009, Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis, Genes Immun, 10, 201, 10.1038/gene.2009.11
Elder, 2010, Molecular dissection of psoriasis: integrating genetics and biology, J Invest Dermatol, 130, 1213, 10.1038/jid.2009.319
Nestle, 2005, Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production, J Exp Med, 202, 135, 10.1084/jem.20050500
Locksley, 2001, The TNF and TNF receptor superfamilies: integrating mammalian biology, Cell, 104, 487, 10.1016/S0092-8674(01)00237-9
Di Cesare, 2009, The IL-23/Th17 axis in the immunopathogenesis of psoriasis, J Invest Dermatol, 129, 1339, 10.1038/jid.2009.59
Steinman, 2007, A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage, Nat Med, 13, 139, 10.1038/nm1551
Lowes, 2008, Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells, J Invest Dermatol, 128, 1207, 10.1038/sj.jid.5701213
Kebir, 2007, Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation, Nat Med, 13, 1173, 10.1038/nm1651
Bettelli, 2007, T(H)-17 cells in the circle of immunity and autoimmunity, Nat Immunol, 8, 345, 10.1038/ni0407-345
Parham, 2002, A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R, J Immunol, 168, 5699, 10.4049/jimmunol.168.11.5699
Singh, 2013, Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis, PLoS One, 8, e51752, 10.1371/journal.pone.0051752
Kryczek, 2008, Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis, J Immunol, 181, 4733, 10.4049/jimmunol.181.7.4733
Keijsers, 2014, In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17, J Invest Dermatol, 134, 1276, 10.1038/jid.2013.526
Schön, 2014, The plot thickens while the scope broadens: a holistic view on IL-17 in psoriasis and other inflammatory disorders, Exp Dermatol, 23, 804, 10.1111/exd.12541
Lin, 2011, Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis, J Immunol, 187, 490, 10.4049/jimmunol.1100123
Büchau, 2007, Innate immunity and antimicrobial defense systems in psoriasis, Clin Dermatol, 25, 616, 10.1016/j.clindermatol.2007.08.016
Costa, 2007, Angiogenesis and chronic inflammation: cause or consequence?, Angiogenesis, 10, 149, 10.1007/s10456-007-9074-0
Rosenberger, 2007, Upregulation of hypoxia-inducible factors in normal and psoriatic skin, J Invest Dermatol, 127, 2445, 10.1038/sj.jid.5700874
Teige, 2009, Regulatory T cells control VEGF-dependent skin inflammation, J Invest Dermatol, 129, 1437, 10.1038/jid.2008.375
Elias, 2008, Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis, Am J Pathol, 173, 689, 10.2353/ajpath.2008.080088
Young, 2004, Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset, J Invest Dermatol, 122, 209, 10.1046/j.0022-202X.2003.22107.x
Schön, 2003, The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders, J Invest Dermatol, 121, 951, 10.1046/j.1523-1747.2003.12563.x
Heidenreich, 2008, Angiogenesis: the new potential target for the therapy of psoriasis?, Drug News Perspect, 21, 97, 10.1358/dnp.2008.21.2.1188196
Zibert, 2011, Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions, J Clin Invest, 121, 410, 10.1172/JCI41295
Hall, 2012, Psychological stress and the cutaneous immune response: roles of the HPA axis and the sympathetic nervous system in atopic dermatitis and psoriasis, Dermatol Res Pract, 2012, 403908, 10.1155/2012/403908
Madva, 2013, Nerve-derived transmitters including peptides influence cutaneous immunology, Brain Behav Immun, 34, 1, 10.1016/j.bbi.2013.03.006
Reich, 2012, The concept of psoriasis as a systemic inflammation: implications for disease management, J Eur Acad Dermatol Venereol, 26, 3, 10.1111/j.1468-3083.2011.04410.x
Farber, 1974, The natural history of psoriasis in 5,600 patients, Dermatologica, 148, 1, 10.1159/000251595
Henseler, 1985, Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris, J Am Acad Dermatol, 13, 450, 10.1016/S0190-9622(85)70188-0
Nair, 2006, Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene, Am J Hum Genet, 78, 827, 10.1086/503821
Trembath, 1997, Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis, Hum Mol Genet, 6, 813, 10.1093/hmg/6.5.813
Capon, 2012, Psoriasis and other complex trait dermatoses: from Loci to functional pathways, J Invest Dermatol, 132, 915, 10.1038/jid.2011.395
Tsoi, 2012, Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity, Nat Genet, 44, 1341, 10.1038/ng.2467
Capon, 2007, Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis, Hum Genet, 122, 201, 10.1007/s00439-007-0397-0
Cargill, 2007, A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes, Am J Hum Genet, 80, 273, 10.1086/511051
Haider, 2008, Cellular genomic maps help dissect pathology in human skin disease, J Invest Dermatol, 128, 606, 10.1038/sj.jid.5701067
Asumalahti, 2003, Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis, J Invest Dermatol, 120, 627, 10.1046/j.1523-1747.2003.12094.x
Rahman, 2009, Association of interleukin 23 receptor variants with psoriatic arthritis, J Rheumatol, 36, 137, 10.3899/jrheum.080458
Villanova, 2013, Biomarkers in psoriasis and psoriatic arthritis, Ann Rheum Dis, 72, ii104, 10.1136/annrheumdis-2012-203037
Wolf, 2008, Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease, J Med Genet, 45, 114, 10.1136/jmg.2007.053595
Hébert, 2012, Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy, Br J Dermatol, 166, 474, 10.1111/j.1365-2133.2011.10712.x
Tejasvi, 2012, TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis, J Invest Dermatol, 132, 593, 10.1038/jid.2011.376
Talamonti, 2013, Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab, Br J Dermatol, 169, 458, 10.1111/bjd.12331
Henseler, 1995, Disease concomitance in psoriasis, J Am Acad Dermatol, 32, 982, 10.1016/0190-9622(95)91336-X
Gerdes, 2008, Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis, Br J Dermatol, 159, 1116
Abuabara, 2010, Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK, Br J Dermatol, 163, 586, 10.1111/j.1365-2133.2010.09941.x
Gupta, 2013, Genetic control of psoriasis is relatively distinct from that of metabolic syndrome and coronary artery disease, Exp Dermatol, 22, 552, 10.1111/exd.12192
Gelfand, 2006, The risk of lymphoma in patients with psoriasis, J Invest Dermatol, 126, 2194, 10.1038/sj.jid.5700410
Gisondi, 2007, Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study, Br J Dermatol, 157, 68, 10.1111/j.1365-2133.2007.07986.x
Gelfand, 2006, Risk of myocardial infarction in patients with psoriasis, JAMA, 296, 1735, 10.1001/jama.296.14.1735
Mallbris, 2004, Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients, Eur J Epidemiol, 19, 225, 10.1023/B:EJEP.0000020447.59150.f9
Ludwig, 2007, Psoriasis: a possible risk factor for development of coronary artery calcification, Br J Dermatol, 156, 271, 10.1111/j.1365-2133.2006.07562.x
Armstrong, 2013, Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies, J Am Heart Assoc, 2, e000062, 10.1161/JAHA.113.000062
Samarasekera, 2013, Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis, J Invest Dermatol, 133, 2340, 10.1038/jid.2013.149
Xu, 2012, Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies, Br J Dermatol, 167, 1345, 10.1111/bjd.12002
Armstrong, 2011, A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis, Exp Dermatol, 20, 544, 10.1111/j.1600-0625.2011.01308.x
Boehncke, 2011, Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study, J Eur Acad Dermatol Venereol, 25, 1187, 10.1111/j.1468-3083.2010.03947.x
Boehncke, 2011, The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity, Exp Dermatol, 20, 303, 10.1111/j.1600-0625.2011.01261.x
Brezinski, 2014, Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review, Curr Pharm Des, 20, 513, 10.2174/138161282004140213123852
Ahern, 2013, Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study, J Eur Acad Dermatol Venereol, 27, 1440, 10.1111/j.1468-3083.2012.04609.x
Horreau, 2013, Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review, J Eur Acad Dermatol Venereol, 27, 12, 10.1111/jdv.12163
Dowlatshahi, 2013, Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study, J Invest Dermatol, 133, 2347, 10.1038/jid.2013.131
Nijsten, 2009, Complexity of the association between psoriasis and comorbidities, J Invest Dermatol, 129, 1601, 10.1038/jid.2009.55
Nast, 2012, S3—guidelines on the treatment of psoriasis vulgaris (English version). Update, J Dtsch Dermatol Ges, 10, S1, 10.1111/j.1610-0387.2012.07919.x
Hsu, 2012, Consensus guidelines for the management of plaque psoriasis, Arch Dermatol, 148, 95, 10.1001/archdermatol.2011.1410
Pathirana, 2009, European S3-guidelines on the systemic treatment of psoriasis vulgaris, J Eur Acad Dermatol Venereol, 23, 1, 10.1111/j.1468-3083.2009.03389.x
Papp, 2013, Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study, J Eur Acad Dermatol Venereol, 27, e376, 10.1111/j.1468-3083.2012.04716.x
Langley, 2014, Secukinumab in plaque psoriasis—results of two phase 3 trials, N Engl J Med, 24, 326, 10.1056/NEJMoa1314258
Mason, 2013, Topical treatments for chronic plaque psoriasis of the scalp: a systematic review, Br J Dermatol, 169, 519, 10.1111/bjd.12393
Saurat, 2008, Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION), Br J Dermatol, 158, 558, 10.1111/j.1365-2133.2007.08315.x
Mrowietz, 2011, Definition of treatment goals for moderate to severe psoriasis: a European consensus, Arch Dermatol Res, 303, 1, 10.1007/s00403-010-1080-1
de Vries, 2013, Interventions for nail psoriasis, Cochrane Database Syst Rev, 1, 10.1002/14651858.CD007633.pub2
Gottlieb, 2013, Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting, J Rheumatol, 40, 1428, 10.3899/jrheum.130456
Coto-Segura, 2013, Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis, Br J Dermatol, 169, 783, 10.1111/bjd.12473
Armstrong, 2013, The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies, J Hypertens, 31, 433, 10.1097/HJH.0b013e32835bcce1
Armstrong, 2012, The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies, Nutr Diabetes, 2, e54, 10.1038/nutd.2012.26
Miller, 2013, Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors, J Am Acad Dermatol, 69, 1014, 10.1016/j.jaad.2013.06.053
Gu, 2013, Psoriasis and risk of cardiovascular disease: a meta-analysis of cohort studies, Int J Cardiol, 168, 4992, 10.1016/j.ijcard.2013.07.127
van der Voort, 2014, Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study, J Am Acad Dermatol, 70, 517, 10.1016/j.jaad.2013.10.044
Daudén, 2013, Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis, J Eur Acad Dermatol Venereol, 27, 1387, 10.1111/jdv.12024
Wohlrab, 2013, Recommendations for detection of individual risk for comorbidities in patients with psoriasis, Arch Dermatol Res, 305, 91, 10.1007/s00403-013-1318-9
Amherd-Hoekstra, 2010, Psoriatic arthritis: a review, J Dtsch Dermatol Ges, 8, 332, 10.1111/j.1610-0387.2009.07334_supp.x
Veale, 2002, Psoriatic arthritis—pathogenesis and epidemiology, Clin Exp Rheumatol, 20, S27
Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N Engl J Med, 352, 1685, 10.1056/NEJMra043430
Kim, 2006, Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms, Circulation, 113, 1888, 10.1161/CIRCULATIONAHA.105.563213
Ahlehoff, 2013, Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study, J Intern Med, 273, 197, 10.1111/j.1365-2796.2012.02593.x
Armstrong, 2014, Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review, Curr Pharm Des, 20, 500, 10.2174/138161282004140213123505
Ryan, 2014, Research gaps in psoriasis: opportunities for future studies, J Am Acad Dermatol, 70, 146, 10.1016/j.jaad.2013.08.042
Hoffmann, 2011, Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction, Br J Dermatol, 165, 1355, 10.1111/j.1365-2133.2011.10555.x
Schön, 2011, Predicting the unpredictable: autoantibody profile as parameter to foretell individual responses to infliximab treatment?, Br J Dermatol, 165, 1160, 10.1111/j.1365-2133.2011.10677.x
Hsu, 2014, Antidrug antibodies in psoriapansis: a systematic review, Br J Dermatol, 170, 261, 10.1111/bjd.12654
Raut, 2013, Psoriasis clinical implications and treatment: a review, Crit Rev Ther Drug Carrier Syst, 30, 183, 10.1615/CritRevTherDrugCarrierSyst.2013005268
Wozel, 2008, Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas, Clin Dermatol, 26, 448, 10.1016/j.clindermatol.2007.10.026
Sticherling, 2011, Therapy of psoriasis in childhood and adolescence—a German expert consensus, J Dtsch Dermatol Ges, 9, 815
Xu, 2013, MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40, J Immunol, 190, 678, 10.4049/jimmunol.1202695
Lowes, 2013, The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses, Trends Immunol, 34, 174, 10.1016/j.it.2012.11.005
Schön, 2008, Animal models of psoriasis: a critical appraisal, Exp Dermatol, 17, 703, 10.1111/j.1600-0625.2008.00751.x
Kumari, 2013, Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice, Immunity, 39, 899, 10.1016/j.immuni.2013.10.009
Augustin, 2008, Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany, Dermatology, 216, 366, 10.1159/000119415
Augustin, 2014, German psoriasis registry PsoBest: objectives, methodology and baseline data, J Dtsch Dermatol Ges, 12, 48
Woth, 2013, Endothelial cells are highly heterogeneous at the level of cytokine-induced insulin resistance, Exp Dermatol, 22, 714, 10.1111/exd.12235